| Gene symbol | CLDN18 | Synonyms | SFTA5, SFTPJ | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q22.3 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | claudin 18 | ||||
| GTO ID | GTC2477 |
| Trial ID | NCT04581473 |
| Disease | Gastroesophageal Adenocarcinoma | Pancreatic Cancer | Gastric Adenocarcinoma |
| Altered gene | CLDN18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT041 |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection |
| Year | 2020 |
| Country | China |
| Company sponsor | CARsgen Therapeutics Co., Ltd. |
| Other ID(s) | CT041-ST-01 |
| Cohort 1 | |||||||||
|
|||||||||